Feirza 1.5/30

Pharmacies, wholesalers, and distributors that stock oral contraceptives need a product they can dispense with confidence and reorder without disruption. Feirza 1.5/30 from Xiromed answers that need. This combined oral contraceptive pairs Ethinyl Estradiol with Levonorgestrel and adds a ferrous fumarate iron tablet, giving your inventory a dependable, widely prescribed option backed by consistent manufacturing and clear specifications.

Product Overview

Feirza 1.5/30 is a combined oral contraceptive (COC) supplied at a strength of 0.03 mg / 1.5 mg, paired with 75 mg ferrous fumarate iron tablets. Each carton holds three blister cards of 28 tablets, for a total of 84 tablets per pack. That 3 x 28 configuration lines up with standard 28-day contraceptive cycles, which reduces refill gaps for patients and simplifies dispensing routines for your team.

Every active tablet delivers a fixed dose of both hormones, while the accompanying iron tablets round out the 28-day cycle. This layout removes the guesswork that separate-component regimens can introduce and helps pharmacists dispense with precision. The predictable pack structure also keeps your reorder rhythm clean, so stock moves through your shelf in step with patient demand.

Feirza 1.5/30 carries NDC 70700-309-85, so buyers can verify the exact configuration before placing an order and match it accurately against inventory systems. For distributors building out a women’s health or contraceptive category, this product slots in cleanly. It fills a well-established therapeutic need, ships in a familiar pack size, and comes with the documentation your compliance and procurement teams expect from a reliable supplier.

Active Ingredients and Their Roles

The value of any combined oral contraceptive lies in how its components work together. Feirza 1.5/30 brings together well-known agents, each with a defined purpose within the regimen.

Ethinyl Estradiol (0.03 mg) is the estrogen component. In a combined oral contraceptive, the estrogen works alongside the progestin to support cycle regulation and contribute to the overall contraceptive effect. The 0.03 mg dose reflects a familiar low-dose estrogen level, aligning Feirza 1.5/30 with widely used prescribing patterns.

Levonorgestrel (1.5 mg) is the progestin component. Levonorgestrel is a well-established progestin in contraceptive practice, and its pairing with ethinyl estradiol represents a long-recognized combination. Within the fixed-dose tablet, it supports the core contraceptive effect and works alongside the estrogen to shape the overall hormonal profile.

Ferrous Fumarate (75 mg) is included as an iron supplement. These non-hormonal iron tablets complete the 28-day pack and provide a source of supplemental iron during the cycle. They do not contribute to the contraceptive effect but help round out the treatment schedule in a single, convenient pack.

By delivering the hormones and the iron component in one coordinated 28-day regimen, Feirza 1.5/30 keeps the routine straightforward. Patients take a single tablet each day rather than managing multiple products, and dispensers handle one SKU. That simplicity supports adherence and streamlines day-to-day pharmacy operations.

Indications and Use

Feirza 1.5/30 belongs to the combined oral contraceptive category and is intended for use under the direction of a qualified healthcare professional. Products of this type are commonly prescribed for the prevention of pregnancy in patients who choose to use an oral contraceptive.

Prescribing decisions, dosing, patient selection, screening, and treatment duration should always follow the approved product labeling and the clinical judgment of the treating physician. This description is written for licensed professionals and authorized trade partners and is not a substitute for the full prescribing information. Always confirm indications, contraindications, and directions against the current labeling before dispensing.

Pack Configuration and Key Details

Clear specifications reduce ordering errors and keep procurement moving. Confirm the following before adding Feirza 1.5/30 to your catalog:

Detail	Specification
Product name	Feirza 1.5/30
Active ingredients	Ethinyl Estradiol / Levonorgestrel
Strength	0.03 mg / 1.5 mg per tablet
Additional component	Ferrous Fumarate 75 mg (iron supplement tablets)
Pack size	3 x 28 tablets (84 tablets total)
NDC	70700-309-85
Dosage form	Oral tablet
Category	Combined oral contraceptive with iron
Supplier	Xiromed

The three-card layout maps to consecutive 28-day cycles, so patients move through a full treatment period without needing an early refill. For pharmacy operations, that means fewer partial-supply issues and a cleaner, more predictable reorder pattern. Verify the NDC against your systems before each order to keep shipments matched.

Why Source Through Xiromed

Reliable supply matters as much as the product itself. Xiromed manufactures its portfolio to meet stringent regulatory standards, and Feirza 1.5/30 holds to the same benchmark. Each batch is produced with consistency in mind, so your supply chain receives a product that performs the same way order after order.

Sourcing Feirza 1.5/30 directly through Xiromed gives buyers verified specifications, a confirmed NDC for accurate matching, and a supply relationship built around the demands of pharmacies and distributors. When availability and documentation both matter, working with a manufacturer that prioritizes each makes procurement simpler.

If you are expanding your contraceptive offering or securing a steady source for an existing line, Feirza 1.5/30 is a straightforward addition. To order or request further product information, connect with the Xiromed team and reference NDC 70700-309-85 to confirm the exact 0.03 mg / 1.5 mg, 3 x 28 pack configuration for your inventory.

---

This information is intended for licensed healthcare professionals, pharmacies, and authorized distributors. Feirza 1.5/30 is a prescription product and should be used only as directed by a qualified healthcare provider in accordance with the approved product labeling. Product availability, specifications, and regulatory status may vary by region. Refer to the full prescribing information before dispensing.